Dependence in Medical Technology
Navigation Links
Dependence in Medical Technology
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... Highlighted at the College on Problems of Drug dependence Annual Meeting RENO, Nev., June 25 ... from the forward-looking statements include dependence on King's ability to conduct its presentations as planned; dependence on the Company's ability to continue to advance ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... trials; risk associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... as well as heroin). Local problems with opioid dependence reflect the national data on this growing public ... use of opioid painkillers. Resources for Opioid dependence and Its Treatment Any physician may take the ... who need more information about opioid dependence and its treatment, either for themselves or for ...
... depression and constipation. When opioid consumption is ongoing, physical dependence can and will develop. This, in turn, can lead to problematic withdrawal ... and non-cancer related, anesthesiologists have the greatest risk of opioid dependence and abuse among health care providers. Also in the high-risk group for ...
... to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks ...
... resources and access to capital to fund required clinical trials, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks ...
... and commercialization, if any, of Novavax's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; competition for clinical resources and patient ...
... Highlighted at the College on Problems of Drug dependence Annual Meeting RENO, Nev., June 25 ... from the forward-looking statements include dependence on King's ability to conduct its presentations as planned; dependence on the Company's ability to continue to advance ...
Neurocrine Biosciences Presents Elagolix Data
... trials; risk associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Human Genome Sciences Submits Biologics License Application to FDA for ABthrax(TM)
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... trials; risk associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Indevus Pharmaceuticals Announces PRO 2000 Found to Show Promise in Large HIV Prevention Study
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA(R), SANCTURA XR(TM), ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly for ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, its ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Neurocrine Biosciences Announces Successful Elagolix PETAL Study in Endometriosis
... trials; risk associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
Human Genome Sciences Reports Progress With Late-Stage Products and New Initiatives
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Indevus Presents Successful Phase III NEBIDO(R) Data at American Urological Association
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...Neurocrine Biosciences Reports First Quarter 2008 Results
... trials; risk associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Indevus Pharmaceuticals Provides Update on PRO 2000 Program
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
... trials; risks associated with the Company's dependence on corporate collaborators for development, ... candidates; risk relating to the Company's dependence on contract manufacturers for clinical drug supply; risks associated with the Company's dependence on corporate collaborators for commercial ...Human Genome Sciences Modifies Dosing in Achieve Trials of Albuferon(R)
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...Indevus Reports Additional Positive Phase III Trial Data for NEBIDO(R)
... elsewhere, and include, but are not limited to: dependence on the success of SANCTURA, SANCTURA XR, NEBIDO, ... spending, third-party relationships and revenues; dependence on third parties for supplies, particularly ... having limited patents and proprietary rights; dependence on market exclusivity, changes in reimbursement ...New Approach to Treating Anthrax Significantly Improves Survival Rates in Pivotal Efficacy Studies
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...
... as well as heroin). Local problems with opioid dependence reflect the national data on this growing public ... use of opioid painkillers. Resources for Opioid dependence and Its Treatment Any physician may take the ... who need more information about opioid dependence and its treatment, either for themselves or for ...
Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
... of the Company's unproven business model, its dependence on new technologies, the uncertainty and timing ... to develop and commercialize products, its dependence on collaborators for services and revenue, ... intellectual property protection, the Company's dependence on key management and key suppliers, the ...... depression and constipation. When opioid consumption is ongoing, physical dependence can and will develop. This, in turn, can lead to problematic withdrawal ... and non-cancer related, anesthesiologists have the greatest risk of opioid dependence and abuse among health care providers. Also in the high-risk group for ...
... to fund required clinical trials or commercialization of PROVENGE, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks ...
... resources and access to capital to fund required clinical trials, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks ...
Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
... resources and access to capital to fund required clinical trials, our dependence on the efforts of third parties, and our dependence on intellectual property. Further information on the factors and risks ...Prometheus and Rosetta Genomics Announce License and Collaboration Agreement
... to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales and ... to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those ...... and commercialization, if any, of Novavax's proposed product candidates; dependence on the efforts of third parties; dependence on intellectual property; competition for clinical resources and patient ...
Other ContentsbadbadbadbadbadbadbalancedbalancedbalancedbalancedbalancedbalancedbalancedbalancedbalancedbehaviorbehaviorbehaviorbehaviorbehaviorbehaviorbehaviorbehaviorbariumbariumbarotraumabasalbasalbasalbasalbasalbasalbasalbasalOther TagsTRIATRIATRIATRIATRIATRIATRIAABBABBABBABBABBHoolHoolCuttersOpmiOther Tagsgift 2gift 3gift 4million 2million 3million 4million 5million 6million 7million 8million 9million 10hundred 2hundred 3hundred 4hundred 5hundred 6hundred 7hundred 8hundred 9hundred 10patch 2patch 3patch 4oral 2oral 3oral 4oral 5oral 6oral 7oral 8oral 9oral 10try 2try 3try 4try 5try 6try 7try 8try 9try 10lungs 2lungs 3
(Date:11/26/2009)... Whitehead researchers have developed a new type o...fic genes and proteins used by pathogens, accordin...ell cultures genes are present in two copies: one ... Gene inactivation by mutation is therefore ineffi...cond copy usually remains active and takes over. ,...
(Date:11/25/2009)...omach, may be used to boost resistance to, or slow...ool of Medicine researchers report in a study publ...ience . , Parkinson,s disease is caused by a deg...dbrain known as the substantia nigra, which is res...ion of dopamine in late-stage Parkinson,s causes s...
(Date:11/25/2009)...is the linchpin of the environment, where atmosphe... many students see soil as "just dirt" a place to...tors are challenged with the task of helping stude...ce of soil in the environment. , A collaborativ...rs at University of Nebraska-Lincoln, Oregon State...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Hormone ghrelin can boost resistance to Parkinson's disease 2It's not just dirt! 2New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 1New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 2New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 3New Breastfeeding Supplement Designed to Improve Milk Production for Nursing Mothers 53572 4The way you eat may affect your risk for breast cancer 9464 1The way you eat may affect your risk for breast cancer 9464 2The way you eat may affect your risk for breast cancer 9464 3Restoring a natural root signal helps to fight a major corn pest 9462 1Restoring a natural root signal helps to fight a major corn pest 9462 2Restoring a natural root signal helps to fight a major corn pest 9462 3(Date:11/27/2009)...d medical, economic burdens, study predicts , ...mber of people with diabetes in the United States ...w study predicts. , That would bring the total ...ase, up from 23.7 million today. , , At the same...ill triple, the study also warns, rising from an e...
(Date:11/27/2009)...t manufacturers who use medical load cells at the ...lars by bringing in technology partner Flintec ear...o-active medical manufacturers are calling in Flin...r projects, ensuring that progress will not be con...ly outdated technology. , ...
(Date:11/26/2009)...of Americans living with diabetes will nearly doub...illion in 2034. Over the same period, spending on ...ion to $336 billion, even with no increase in the ...iversity of Chicago report in the December issue o...abetes covered by Medicare will rise from 8.2 mill...
(Date:11/26/2009)...etters from the North Pole, Textsanta.net lets par...anta , North Pole, AK (PR...iencies at the North Pole Santa Claus has added SM...e globe informed of his Christmas progress at the ...partment have identified a large and growing perce...
(Date:11/26/2009)...p; Ennis, P.A. is offering free nationwide confide...rth control pills who have suffered a Deep Vein Th...Attack or other related cardiac issues or had thei... 1-800-856-6405 or go to the firm’s website ...e case evaluation form. , ...
Breaking Medicine News(10 mins):Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4Health News:Diabetes cases to double and costs to triple by 2034 2Health News:Diabetes cases to double and costs to triple by 2034 3Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 2Health News:Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills 3[0] Diabetes Cases Expected to Double in 25 Years[0] Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells[0] Diabetes cases to double and costs to triple by 2034[1] Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes[0] Ennis & Ennis, P.A. Announces Nationwide Free, Confidential, Consultations For Users Of Yaz And Yasmin Birth Control Pills
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |